Rationale for and Results of a Phase I Study of the TGF-β 1/3 Inhibitor AVID200 in Subjects with Myelofibrosis: MPN-RC 118 Trial
| Autor: | Mascarenhas, John, Kosiorek, Heidi E. *, Varricchio, Lilian *, Bhave, Rupali *, Kuykendall, Andrew T., Komrokji, Rami, Gerds, Aaron T., Palmer, Jeanne M., Gabler, Amelia R. *, Sandy, Lonette *, Migliaccio, Anna Rita, Salama, Mohamed E, Weinberg, Rona Singer, O'Connor-McCourt, Maureen *, Tremblay, Gilles *, Nadler, Paul I., Dueck, Amylou C., Mesa, Ruben A., Hoffman, Ronald |
|---|---|
| Zdroj: | In Blood 5 November 2020 136 Supplement 1:6-8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|